Novartis is attending the 44th Annual J.P. Morgan Healthcare Conference in San Francisco from 12-16 January 2026.
Header
J.P. Morgan Healthcare Conference 2026
San Francisco, USA
Novartis company presentation
On Monday January 12, Novartis CEO, Vas Narasinham, gave an extensive and detailed overview of our portfolio and a deep dive into the four Therapeutic Areas. You can learn more by exploring the link to the PDF file below and listening to a live recording of the session.
AUDIO
Highlights of the Novartis Growth Story presentation
Slide 9
Robust portfolio provides a strong foundation for growth, diversified across high-growth therapeutic areas and advanced technology platforms.
Slide 11
Expect net sales to grow +5-6% cc CAGR from 2025 to 2030 and core margin to return to 40%+ by 2029.
Slide 29
The 3 pillars of our financial stability and growth trajectory.
In the news
Explore some recent media coverage explaining our performance, strategy and approach to business development
Strategy
Learn about the Novartis strategy and explore our core therapeutic areas and technology platforms.
Investor Relations
We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.